What happened
Aprogen Biologics disclosed convertible bonds to raise $14M (₩20B), about 49.2% of its market value.
For context, this raise equals about 49.2% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | $14M (₩20B) |
| vs. market value | 49.2% |
| Filed | 2026-09-03, 주요사항보고서(유상증자결정) |
| Source | DART rcept 20260903000316 → open original filing |
Source: DART. Information only, not investment advice.